Bost M - Search Results

1

Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings.

Ben Othmen L, Mechri A, Fendri C, Bost M, Chazot G, Gaha L, Kerkeni A. Ben Othmen L, et al. Among authors: bost m. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):155-9. doi: 10.1016/j.pnpbp.2007.08.003. Epub 2007 Aug 14. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17804133

2

Peripheral blood markers of oxidative stress in Parkinson's disease.

Younes-Mhenni S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G. Younes-Mhenni S, et al. Among authors: bost m. Eur Neurol. 2007;58(2):78-83. doi: 10.1159/000103641. Epub 2007 Jun 12. Eur Neurol. 2007. PMID: 17565220

3

Serum copper, zinc and selenium levels in Tunisian patients with Parkinson's disease.

Younes-Mhenni S, Aissi M, Mokni N, Boughammoura-Bouatay A, Chebel S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G, Sfar MT, Sfar MH. Younes-Mhenni S, et al. Among authors: bost m. Tunis Med. 2013 Jun;91(6):402-5. Tunis Med. 2013. PMID: 23868039

4

Modelization of motor nerve conduction velocities for Charcot-Marie-Tooth (Type-1) patients. CMT-France Network.

Sturtz FG, Chauvin F, Ollagnon-Roman E, Bost M, Latour P, Bonnebouche C, Gonnaud PM, Bady B, Chazot G, Vandenberghe A. Sturtz FG, et al. Among authors: bost m. Eur Neurol. 1996;36(4):224-8. doi: 10.1159/000117254. Eur Neurol. 1996. PMID: 8814426

5

New allele of probe D17S61 present in the Charcot-Marie-Tooth 1A duplication.

Bost M, Bonnebouche C, Gonnaud PM, Cochat P, Gilbert B, Dupont C, Chazot G, Vandenberghe A. Bost M, et al. Clin Genet. 1994 Nov;46(5):380-1. doi: 10.1111/j.1399-0004.1994.tb04184.x. Clin Genet. 1994. PMID: 7889651 No abstract available.

6

Molecular diagnosis of Charcot-Marie-Tooth 1A disease and hereditary neuropathy with liability to pressure palsies by quantifying CMT1A-REP sequences: consequences of recombinations at variant sites on chromosomes 17p11.2-12.

Vandenberghe A, Latour P, Chauplannaz G, Chapon F, Pouget J, Dumas R, Laguenay A, Ollagnon E, Bost M, Duthel S, Chazot G, Boucherat M. Vandenberghe A, et al. Among authors: bost m. Clin Chem. 1996 Jul;42(7):1021-5. Clin Chem. 1996. PMID: 8674184

7

A RsaI RFLP at the human myelin protein zero (MPZ) locus.

Latour P, Bonnebouche C, Bost M, Diraison P, Chapon F, Boucherat M, Vandenberghe A. Latour P, et al. Among authors: bost m. Clin Genet. 1994 Oct;46(4):327-8. doi: 10.1111/j.1399-0004.1994.tb04172.x. Clin Genet. 1994. PMID: 7530611 No abstract available.

8

Restriction polymorphisms of the ceruloplasmin gene on chromosome 3.

Bost M, Berkaw M, McBride OW, Chazot G, Arnaud P. Bost M, et al. Hum Genet. 1995 Aug;96(2):239-40. doi: 10.1007/BF00207390. Hum Genet. 1995. PMID: 7635481

9

[Steinert disease].

Bouhour F, Bost M, Vial C. Bouhour F, et al. Among authors: bost m. Presse Med. 2007 Jun;36(6 Pt 2):965-71. doi: 10.1016/j.lpm.2007.01.002. Epub 2007 Feb 7. Presse Med. 2007. PMID: 17289339 Review. French.

10

Effect of double-blind crossover selenium supplementation on biological indices of selenium status in cystic fibrosis patients.

Portal B, Richard MJ, Ducros V, Aguilaniu B, Brunel F, Faure H, Gout JP, Bost M, Favier A. Portal B, et al. Among authors: bost m. Clin Chem. 1993 Jun;39(6):1023-8. Clin Chem. 1993. PMID: 8504531 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results